Seizures Therapeutic Pipeline Market Review H2 2014 Report at RnRMarketReserach.com

Share Article

RnRMarketResearch.com adds Seizures Pipeline Review H2 2014 to its store. The report contains 80 pages and provides an overview of the Seizures therapeutic pipeline.

Seizures Therapeutic Pipeline Market

Seizures Therapeutic Pipeline Market

The report "Seizures Pipeline Review H2 2014" is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. This report provides comprehensive information on the therapeutic development for Anxiety Disorders, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anxiety Disorders and special features on late-stage and discontinued projects. Complete Report is Available @ http://www.rnrmarketresearch.com/seizures-pipeline-review-h2-2014-market-report.html .

Companies discussed in this Seizures Pipeline Review H2 2014 report include:

  • Acorda Therapeutics, Inc.
  • Advicenne Pharma
  • Alexza Pharmaceuticals, Inc.
  • Concert Pharmaceuticals, Inc.
  • Neurelis, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sage Therapeutics
  • Ultragenyx Pharmaceutical Inc.
  • Upsher-Smith Laboratories, Inc.

Drugs profile discussed in this Seizures Pipeline Review H2 2014 report include ADV-6208, alprazolam, C-10068, CCG-63802, CHEC-9, diazepam, everolimus, Gene Therapy to Activate Neuropeptide Y Receptor Y2 and Y5 for Epilepsy, midazolam hydrochloride, SAGE-217, Small Molecules to Activate TrkB Receptor for Central Nervous System, Metabolic Disorders and ENT Disorders, UX-007. Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=248278 .

Major points in Table of Content
List of Tables
Number of Products under Development for Seizures, H2 2014 9
Number of Products under Development for Seizures - Comparative Analysis, H2 2014 10
Number of Products under Development by Companies, H2 2014 12
Number of Products under Investigation by Universities/Institutes, H2 2014 13
Comparative Analysis by Late Stage Development, H2 2014 14
Comparative Analysis by Clinical Stage Development, H2 2014 15
Comparative Analysis by Early Stage Development, H2 2014 16
Products under Development by Companies, H2 2014 17
Products under Investigation by Universities/Institutes, H2 2014 18
Seizures - Pipeline by Acorda Therapeutics, Inc., H2 2014 19
Seizures - Pipeline by Advicenne Pharma, H2 2014 20
Seizures - Pipeline by Alexza Pharmaceuticals, Inc., H2 2014 21
Seizures - Pipeline by Concert Pharmaceuticals, Inc., H2 2014 22
Seizures - Pipeline by Neurelis, Inc., H2 2014 23
Seizures - Pipeline by Novartis AG, H2 2014 24
Seizures - Pipeline by Pfizer Inc., H2 2014 25
Seizures - Pipeline by Sage Therapeutics, H2 2014 26
Seizures - Pipeline by Ultragenyx Pharmaceutical Inc., H2 2014 27
Seizures - Pipeline by Upsher-Smith Laboratories, Inc., H2 2014 28
Assessment by Monotherapy Products, H2 2014 29
Number of Products by Stage and Target, H2 2014 31
Number of Products by Stage and Mechanism of Action, H2 2014 33
Number of Products by Stage and Route of Administration, H2 2014 35
Number of Products by Stage and Molecule Type, H2 2014 37
Seizures Therapeutics - Recent Pipeline Updates, H2 2014 61
Seizures - Dormant Projects, H2 2014 71
Seizures - Discontinued Products, H2 2014 72

List of Figures
Number of Products under Development for Seizures, H2 2014 9
Number of Products under Development for Seizures - Comparative Analysis, H2 2014 10
Number of Products under Development by Companies, H2 2014 11
Comparative Analysis by Late Stage Development, H2 2014 14
Comparative Analysis by Clinical Stage Development, H2 2014 15
Comparative Analysis by Early Stage Products, H2 2014 16
Assessment by Monotherapy Products, H2 2014 29
Number of Products by Top 10 Targets, H2 2014 30
Number of Products by Stage and Top 10 Targets, H2 2014 31
Number of Products by Top 10 Mechanism of Actions, H2 2014 32
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 33
Number of Products by Top 10 Routes of Administration, H2 2014 34
Number of Products by Stage and Top 10 Routes of Administration, H2 2014 35
Number of Products by Top 10 Molecule Types, H2 2014 36
Number of Products by Stage and Top 10 Molecule Types, H2 2014 37

Explore more reports on Neurology therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/neurology-therapeutics .

About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
@chinamrreport
Follow >
Market Reports China
Like >
Follow us on
Visit website